Jazz Pharma Plc (JAZZ)
$104.43
5.67 (5.74%)
JAZZ Stock Quote Delayed 20 Minutes
Previous Close
$98.76
Market Cap
6.05B
PE Ratio
14.31
EPS
7.3
Volume (Avg. Vol.)
201,168
Day's Range
100.08 - 105.56
52-Week Range
86.88 - 154.24
Dividend & Yield
N/A (N/A)
JAZZ Stock Predictions, Articles, and Jazz Pharma Plc News
5 Safe Stocks to Buy With Low Price-to-Book Ratios
P/B ratio is a convenient tool to identify low-priced stocks that have high-growth prospects. Here are five stocks with low P/B ratios.
5 Low Price-to-Book Stocks Worth Buying in July
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects. Compare Brokers....
10 Pharmaceuticals Stocks to Sell Now
This week, the ratings of 10 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Is 70% an Excessive Premium for Celator Pharmaceuticals Inc? (CPXX JAZZ)
Jazz Pharmaceuticals stock is hovering around breakeven after agreeing to acquire Celator (CPXX) for a 73% premium. Does the deal make sense?
The Best 7 Stocks to Buy for 2016
Was 2015 the final nail in the coffin for buy-and-hold investing? Not necessarily. Buy these 7 names and hold for 2016 before letting them go
2 Biotech Stocks to Buy After Earnings
Actavis (ACT) and Jazz Pharmaceuticals (JAZZ) reported outstanding Q3 earnings and are strong biotech stocks to buy.
Why I Believe Markets Are Rigged
Can we learn to thrive in the HFT/algo world of high speed trading? Here are some tips and ideas on how to copy in a fast moving market
Say Yes to Drugs with a Jazz Pharmaceuticals Credit Spread (JAZZ)
Two of Jazz Pharmaceuticals' drugs are showing record growth, and the stock just keeps making new highs. Can it last?
America’s 10 Fastest Growing Companies
These are the 10 fastest-growing companies in the world according to Fortune.
5 Pharmaceutical Stocks to Buy Now
This week, five Pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
A Healthy Portfolio Is Heavy in Health Care
Investors would be foolish to ignore the massive demographic shift and growth potential that is boosting health care stocks right now.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
